» Articles » PMID: 38100416

Instrumental Variables Methods Reconcile Intention-to-screen Effects Across Pragmatic Cancer Screening Trials

Overview
Specialty Science
Date 2023 Dec 15
PMID 38100416
Authors
Affiliations
Soon will be listed here.
Abstract

Pragmatic cancer screening trials mimic real-world scenarios in which patients and doctors are the ultimate arbiters of treatment. Intention-to-screen (ITS) analyses of such trials maintain randomization-based apples-to-apples comparisons, but differential adherence (the failure of subjects assigned to screening to get screened) makes ITS effects hard to compare across trials and sites. We show how instrumental variables (IV) methods address the nonadherence challenge in a comparison of estimates from 17 sites in five randomized trials measuring screening effects on colorectal cancer incidence. While adherence rates and ITS estimates vary widely across and within trials, IV estimates of per-protocol screening effects are remarkably consistent. An application of simple IV tools, including graphical analysis and formal statistical tests, shows how differential adherence explains variation in ITS impact. Screening compliers are also shown to have demographic characteristics similar to those of the full trial study sample. These findings argue for the clinical relevance of IV estimates of cancer screening effects.

Citing Articles

Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates.

Bonander C, Jakobsson N, Kemp Gudmundsdottir K, Svennberg E, Engdahl J Europace. 2025; 27(2).

PMID: 39953895 PMC: 11878575. DOI: 10.1093/europace/euaf030.


Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum.

Lund J, Rivera M, Su I, Long J, Chen X, Pak J Cancer Epidemiol Biomarkers Prev. 2024; 33(8):984-988.

PMID: 39012954 PMC: 11351907. DOI: 10.1158/1055-9965.EPI-23-1491.


Instrumental variables for implementation science: exploring context-dependent causal pathways between implementation strategies and evidence-based interventions.

Mody A, Filiatreau L, Goss C, Powell B, Geng E Implement Sci Commun. 2023; 4(1):157.

PMID: 38124203 PMC: 10731809. DOI: 10.1186/s43058-023-00536-x.

References
1.
Holme O, Loberg M, Kalager M, Bretthauer M, Hernan M, Aas E . Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014; 312(6):606-15. PMC: 4495882. DOI: 10.1001/jama.2014.8266. View

2.
Dominitz J, Robertson D . Understanding the Results of a Randomized Trial of Screening Colonoscopy. N Engl J Med. 2022; 387(17):1609-1611. DOI: 10.1056/NEJMe2211595. View

3.
Rembold C . Number needed to screen: development of a statistic for disease screening. BMJ. 1998; 317(7154):307-12. PMC: 28622. DOI: 10.1136/bmj.317.7154.307. View

4.
Lee Y, Kennedy E, Mitra N . Doubly robust nonparametric instrumental variable estimators for survival outcomes. Biostatistics. 2021; 24(2):518-537. DOI: 10.1093/biostatistics/kxab036. View

5.
Glasziou P . Meta-analysis adjusting for compliance: the example of screening for breast cancer. J Clin Epidemiol. 1992; 45(11):1251-6. DOI: 10.1016/0895-4356(92)90166-k. View